Natural history of post-operative non-functioning pituitary adenomas - a single centre cohort analysis

被引:0
|
作者
Shaikh, Salman T. [1 ]
Moughal, Saad [1 ]
Wael, Mohamed [1 ]
Nix, Paul [2 ]
Tyagi, Atul [1 ]
Phillips, Nick [1 ]
Sheikh, Asim [1 ,3 ]
机构
[1] Leeds Gen Infirm, Dept Neurosurg, Leeds, England
[2] Leeds Gen Infirm, Dept ENT, Leeds, England
[3] Leeds Gen Infirm, Leeds, England
关键词
Growth rate; non-functioning; pituitary adenomas; radiology; FOLLOW-UP; MACROADENOMAS; APOPLEXY; RISK;
D O I
10.1080/02688697.2023.2284789
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
PurposeTo study behaviour of endonasally operated non-functioning pituitary adenomas (NFPA) and propose a cost-effective stratified follow-up regimen.MethodsA single centre retrospective cohort analysis from June 2009 till December 2019. All endonasally operated pituitary adenomas were identified with sub-analysis of the NFPA's. Patients of all age groups with radiological follow-up more than 30 months were included. Patients with any kind of cranial intervention performed < within 30 months of surgery were excluded. The post-operative MRI for this cohort was evaluated until either any intervention was performed or until the last follow-up. The maximal tumour diameter in any plane (mm) was measured from the MRI scans. The annual growth rate and the statistical relationship between age, sex, IHC, Ki-67, resection %, residual tumour was calculated.ResultsOut of 610 pituitary adenomas identified in the dataset, 116 patients met the inclusion criteria. Follow-up period ranged from 30 to 142 months (mean 78.5 months). A strong relationship existed between predicting tumour progression with first post-operative residue size (p = .001). A statistically significant relationship was found to be present between tumour growth and a residue of less than 10 mm diameter and 11-20 mm in diameter (Log rank p value .0216). On average, each patient with a residue < 5mm had MRI scans costing 976 pound .ConclusionBased on statistical analysis and internal validation of the growth rate of the residue, we have proposed MRI follow-up scans. These recommendations have the potential to save more than 300 per pound patient towards MRI costs and can lay down a marker for defining time interval of serial scans for post-operative NFPA's.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Post-surgical management of non-functioning pituitary adenoma
    Cortet-Rudelli, Christine
    Bonneville, Jean-Francois
    Borson-Chazot, Francoise
    Clavier, Lorraine
    Dequeant, Bernard Coche
    Desailloud, Rachel
    Maiter, Dominique
    Rohmer, Vincent
    Sadoul, Jean Louis
    Sonnet, Emmanuel
    Toussaint, Patrick
    Chanson, Philippe
    ANNALES D ENDOCRINOLOGIE, 2015, 76 (03) : 228 - 238
  • [42] Development and Validation of a Prognostic Model for Post-Operative Recurrence of Pituitary Adenomas
    Lu, Liang
    Wan, Xueyan
    Xu, Yu
    Chen, Juan
    Shu, Kai
    Lei, Ting
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] THE EFFICACY OF EARLY POSTOPERATIVE RADIOTHERAPY FOR NON-FUNCTIONING PITUITARY MACRO ADENOMAS, WITH TUMOUR CELLS EXPRESSING OR NOT EXPRESSING PITUITARY HORMONES
    Stancu, C.
    Cimpean, A. M. G.
    Gheorghiu, M. L.
    Galoiu, S.
    Dumitrascu, A.
    Hortopan, D.
    Anghel, R. M.
    Ciubotaru, V.
    Badiu, C.
    Raica, M.
    Coculescu, M.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2014, 10 (04) : 605 - 620
  • [44] Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas
    T. Chile
    M. L. Corrêa-Giannella
    M. A. H. Z. Fortes
    M. D. Bronstein
    M. B. Cunha-Neto
    D. Giannella-Neto
    R. R. Giorgi
    Journal of Endocrinological Investigation, 2011, 34 : e214 - e218
  • [45] Dopamine 2 and Somatostatin 1-5 Receptors Coexpression in Clinically Non-Functioning Pituitary Adenomas
    Gabalec, F.
    Drastikova, M.
    Cesak, T.
    Netuka, D.
    Masopust, V.
    Machac, J.
    Marek, J.
    Cap, J.
    Beranek, M.
    PHYSIOLOGICAL RESEARCH, 2015, 64 (03) : 369 - 377
  • [46] Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas
    Chile, T.
    Correa-Giannella, M. L.
    Fortes, M. A. H. Z.
    Bronstein, M. D.
    Cunha-Neto, M. B.
    Giannella-Neto, D.
    Giorgi, R. R.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (08) : E214 - E218
  • [47] Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study
    Or Cohen-Inbar
    Zhiyuan Xu
    Cheng-chia Lee
    Chin-Chun Wu
    Tomáš Chytka
    Danilo Silva
    Mayur Sharma
    Hesham Radwan
    Inga S. Grills
    Brandon Nguyen
    Zaid Siddiqui
    David Mathieu
    Christian Iorio-Morin
    Amparo Wolf
    Christopher P. Cifarelli
    Daniel T. Cifarelli
    L. Dade Lunsford
    Douglas Kondziolka
    Jason P. Sheehan
    Journal of Neuro-Oncology, 2017, 135 : 67 - 74
  • [48] Solid tumor size for prediction of recurrence in large and giant non-functioning pituitary adenomas
    Ching-Chung Ko
    Chin-Hong Chang
    Tai-Yuan Chen
    Sher-Wei Lim
    Te-Chang Wu
    Jeon-Hor Chen
    Yu‐Ting Kuo
    Neurosurgical Review, 2022, 45 : 1401 - 1411
  • [49] An evaluation of the effects of somatostatin analogue therapy in non-functioning pituitary adenomas in comparison to acromegaly
    Zawada, Natalia Bozena
    Kunert-Radek, Jolanta
    Pawlikowski, Marek
    Pisarek, Hanna
    Radek, Maciej
    ENDOKRYNOLOGIA POLSKA, 2016, 67 (03) : 292 - 298
  • [50] Is Positive Staining of Non-Functioning Pituitary Adenomas for Luteinizing Hormone Associated with a Poor Prognosis?
    Diri, Halit
    Ozaslan, Ersin
    Kurtsoy, Ali
    Tucer, Bulent
    Simsek, Yasin
    Ozturk, Figen
    Durak, Ahmet Candan
    Erten, Sirac
    Bayram, Fahri
    TURKISH NEUROSURGERY, 2017, 27 (01) : 8 - 13